IP Library › Granted Patent US 11,317,623
Granted Patent B2
US 11,317,623 · App. 16/480,261 · Granted May 3, 2022

Cell-free protein synthesis system

Inventors: Matthias Buntru (Aachen, DE); Simon Vogel (Aachen, DE); Stefan Schillberg (Aachen, DE)
Assignee: FRAUNHOFER-GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E.V.
A01N3/00C12N15/8257C12P21/02
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,317,623
App. No.
16/480,261
Granted
May 3, 2022
Kind
B2
Abstract

The technology provided herein relates to novel methods and systems for cell-free protein synthesis, in particular to cell-free protein synthesis systems suitable for protein synthesis before and after freezing for a short- or long-term storage, wherein said system comprises a cryoprotectant.

Claims (16)

1. A cell-free protein synthesis system suitable for protein synthesis before and after freezing for a short- or long-term storage, wherein said system comprises a cryoprotectant, wherein said cell-free protein synthesis system is a tobacco BY-2 cell lysate, wherein said cryoprotectant is trehalose or dimethyl sulfoxide (DMSO), wherein a concentration of trehalose is in a range between 1.25 and 2.5% w/v and a concentration of DMSO is in a range between 1 and 4% v/v.

2. The cell-free protein synthesis system according to claim 1 , wherein said cell-free protein synthesis system is frozen.

3. The cell-free protein synthesis system according to claim 1 , wherein said cell-free protein synthesis system is stored at a temperature below −50° C., below −60° C., below −70° C., below −80° C., below −90° C. or below −196° C.

4. A method for cell-free protein synthesis, said method comprising the steps of:

a) freezing the cell-free protein synthesis system according to claim 1 to a temperature below −50° C., below −60° C., below −70° C., below −80° C., below −90° C. or below −196° C.;

b) storing said frozen cell-free protein synthesis system;

c) thawing said cell-free protein synthesis system; and

d) synthesizing a protein in vitro by using said cell-free protein synthesis system and a nucleic acid template.

5. The method according to claim 4 , wherein the cryoprotectant is not removed before synthesizing a protein.

6. The method according to claim 4 , wherein the cell-free protein synthesis system is thawed at room temperature before usage.

7. A method of preserving a cell-free protein synthesis system comprising the steps of:

a) contacting a cell-free protein synthesis system with a cryoprotectant to obtain a cell-free protein synthesis system according to claim 1 ; and

b) freezing said cell-free protein synthesis system in contact with said cryoprotectant.

8. The method according to claim 7 , wherein said cell-free protein synthesis system is frozen by shock freezing.

9. The method according to claim 7 , wherein said cell-free protein synthesis system is frozen to a temperature below −50° C., below −60° C., below −70° C., below −80° C., below −90° C. or below −196° C.

10. The method according to claim 7 , wherein the frozen cell-free protein synthesis system is thawed at room temperature before usage.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 10, 2019
From: BUNTRU, MATTHIAS; VOGEL, SIMON; SCHILLBERG, STEFAN
To: FRAUNHOFER-GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E.V.
Reel/Frame 050677/0370 →
Priority Claims (1)
EP 17153005 · Jan 25, 2017 · regional
Continuity (1)
Related Publication 20190380330A1 · Dec 19, 2019